Hill-Rom Holdings, Inc. (NYSE:HRC) SVP Andreas G. Frank sold 7,454 shares of the firm’s stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $95.76, for a total value of $713,795.04. Following the transaction, the senior vice president now directly owns 27,224 shares in the company, valued at approximately $2,606,970.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of NYSE HRC traded down $0.02 during midday trading on Friday, reaching $97.05. 34,627 shares of the company were exchanged, compared to its average volume of 562,867. The company has a quick ratio of 1.30, a current ratio of 1.74 and a debt-to-equity ratio of 1.11. Hill-Rom Holdings, Inc. has a 1 year low of $78.16 and a 1 year high of $98.96. The firm has a market cap of $6.50 billion, a P/E ratio of 20.43, a P/E/G ratio of 1.35 and a beta of 0.90.
Hill-Rom (NYSE:HRC) last released its quarterly earnings results on Friday, November 2nd. The medical technology company reported $1.63 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.51 by $0.12. Hill-Rom had a return on equity of 21.10% and a net margin of 8.86%. The firm had revenue of $759.20 million for the quarter, compared to analyst estimates of $750.90 million. During the same quarter last year, the company posted $1.32 earnings per share. The business’s revenue was up 2.8% on a year-over-year basis. As a group, analysts anticipate that Hill-Rom Holdings, Inc. will post 5.13 earnings per share for the current year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in HRC. Flagship Harbor Advisors LLC purchased a new position in shares of Hill-Rom during the second quarter worth about $173,000. Quantbot Technologies LP boosted its holdings in Hill-Rom by 270.2% in the 3rd quarter. Quantbot Technologies LP now owns 2,051 shares of the medical technology company’s stock valued at $193,000 after purchasing an additional 1,497 shares in the last quarter. First Light Asset Management LLC purchased a new stake in Hill-Rom in the 3rd quarter valued at approximately $202,000. CIBC Asset Management Inc purchased a new stake in Hill-Rom in the 2nd quarter valued at approximately $203,000. Finally, CAPROCK Group Inc. purchased a new stake in Hill-Rom in the 3rd quarter valued at approximately $211,000. 79.75% of the stock is currently owned by hedge funds and other institutional investors.
Several equities analysts have issued reports on the company. Zacks Investment Research raised Hill-Rom from a “hold” rating to a “buy” rating and set a $105.00 price objective on the stock in a report on Wednesday. UBS Group assumed coverage on Hill-Rom in a report on Tuesday. They set a “buy” rating and a $115.00 price objective on the stock. ValuEngine raised Hill-Rom from a “hold” rating to a “buy” rating in a report on Tuesday, November 6th. Raymond James raised their price objective on Hill-Rom from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Monday, November 5th. Finally, Barclays began coverage on Hill-Rom in a report on Monday, October 15th. They set an “equal weight” rating and a $95.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Hill-Rom currently has a consensus rating of “Buy” and a consensus price target of $103.33.
ILLEGAL ACTIVITY NOTICE: This piece of content was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.com-unik.info/2018/11/30/hill-rom-holdings-inc-hrc-svp-andreas-g-frank-sells-7454-shares.html.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Recommended Story: Are analyst ratings accurate?
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.